Trials / Completed
CompletedNCT04601350
Effect of Remimazolam Use During Perioperative Period on Brain Waves and Postoperative Cognitive Function
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Yangzhou University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Benzodiazepine sedative hypnotics are commonly used intravenous anesthetics in clinical practice. Remimazolam is a new benzodiazepine with the characteristics of rapid onset, short maintenance and recovery time, no accumulation, metabolism independent of liver and kidney function, and no serious side effects, which has a good prospect for clinical application. Now we will study the effects of remimazolam on EEG and postoperative cognitive function ,in order to further understand the clinical application of remimazolam.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | remimazolam group was induced with remimazolam 0.1 mg/kg followed by a maintenance dose of 0.1 mg·kg-1·h-1 for general anesthesia | remimazolam group was remimazolam 0.1 mg/kg followed by a maintenance dose of 0.1 mg·kg-1·h-1 for general anesthesia |
| DRUG | control group was induced with midazolam 0.05 mg/kg followed by normal saline maintenance of 0.1 ml·kg-1·h-1 | control group was induced with midazolam 0.05 mg/kg followed by normal saline maintenance of 0.1 ml·kg-1·h-1 |
Timeline
- Start date
- 2020-11-01
- Primary completion
- 2022-05-01
- Completion
- 2022-06-01
- First posted
- 2020-10-23
- Last updated
- 2024-01-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04601350. Inclusion in this directory is not an endorsement.